In Brief: NDAC meetings
This article was originally published in The Tan Sheet
Executive Summary
NDAC meetings: Tentative joint meeting of FDA's Nonprescription Drugs and Dermatologic & Ophthalmic Drugs Advisory Committees scheduled for July 16; topics are still in development. Both committees also are scheduled to meet July 14 and 15. NDAC will meet jointly with the Pulmonary-Allergy Drugs Advisory Committee Sept. 18-19, possibly for reconsideration of the Rx-to-OTC switch of Schering-Plough's Vancenase AQ. Review of the beclomethasone dipropionate nasal spray was postponed last September at the company's request ("The Tan Sheet" Sept. 30, 1996, p. 9). Schering asked for the delay to further analyze its data before presenting before the committee...